dihydrofolate reductase ( fh2-r ) was studied cytochemically in the bone marrow erythroblasts of 20 normal controls and 46 patients with myelodysplastic syndromes ( mdss ) classified according to fab , prior to therapy .
C0005953
bone marrow
C0014762
erythroblasts